RE-BVS – Piemonte Repository

Sfoglia per AUTORE
MOK T
Collezione AOU San Luigi di Orbassano

Items : 10

HERTHENA-Lung02: phase III study of patritumab deruxtecan in advanced EGFR-mutated NSCLC after a third-generation EGFR TKI. in Future oncology (London, England) / Future Oncol. 2024 May;20(15):969-980. doi: 10.2217/fon-2023-0602. Epub 2023 Dec 14.

2024
AOU San Luigi di Orbassano

Mok T; Jänne PA; Nishio M; Novello S; Reck M; Steuer C; Wu YL; Fougeray R; Fan PD; Meng J; Sternberg DW; Esker S; Yu HA; Mok T; Jänne PA; Nishio M; Novello S; Reck M; Steuer C; Wu YL; Fougeray R; Fan PD; Meng J; Sternberg DW; Esker S; Yu HA;

Atezolizumab versus chemotherapy in advanced or metastatic NSCLC with high blood-based tumor mutational burden: primary analysis of BFAST cohort C randomized phase 3 trial. in Nature medicine / Nat Med. 2022 Sep;28(9):1831-1839. doi: 10.1038/s41591-022-01933-w. Epub 2022 Aug 22.

2022
AOU San Luigi di Orbassano

Peters S; Dziadziuszko R; Morabito A; Felip E; Gadgeel SM; Cheema P; Cobo M; Andric Z; Barrios CH; Yamaguchi M; Dansin E; Danchaivijitr P; Johnson M; Novello S; Mathisen MS; Shagan SM; Schleifman E; Wang J; Yan M; Mocci S; Voong D; Fabrizio DA; Shames DS; Riehl T; Gandara DR; Mok T;

Efficacy of Brigatinib in Patients With Advanced ALK-Positive NSCLC Who Progressed on Alectinib or Ceritinib: ALK in Lung Cancer Trial of brigAtinib-2 (ALTA-2). in Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer / J Thorac Oncol. 2022 Dec;17(12):1404-1414. doi: 10.1016/j.jtho.2022.08.018. Epub 2022 Sep 10.

2022
AOU San Luigi di Orbassano

Ou SI; Nishio M; Ahn MJ; Mok T; Barlesi F; Zhou C; Felip E; de Marinis F; Kim SW; Pérol M; Liu G; Migliorino MR; Kim DW; Novello S; Bearz A; Garrido P; Mazieres J; Morabito A; Lin HM; Yang H; Niu H; Zhang P; Kim ES;

Liquid Biopsy for Advanced NSCLC: A Consensus Statement From the International Association for the Study of Lung Cancer. in Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer / J Thorac Oncol. 2021 Oct;16(10):1647-1662. doi: 10.1016/j.jtho.2021.06.017. Epub 2021 Jul 8.

2021
AOU San Luigi di Orbassano

Rolfo C; Mack P; Scagliotti GV; Aggarwal C; Arcila ME; Barlesi F; Bivona T; Diehn M; Dive C; Dziadziuszko R; Leighl N; Malapelle U; Mok T; Peled N; Raez LE; Sequist L; Sholl L; Swanton C; Abbosh C; Tan D; Wakelee H; Wistuba I; Bunn R; Freeman-Daily J; Wynes M; Belani C; Mitsudomi T; Gandara D;

Outcomes With Pembrolizumab Monotherapy in Patients With Programmed Death-Ligand 1-Positive NSCLC With Brain Metastases: Pooled Analysis of KEYNOTE-001, 010, 024, and 042. in JTO clinical and research reports / JTO Clin Res Rep. 2021 Jul 1;2(8):100205. doi: 10.1016/j.jtocrr.2021.100205. eCollection 2021 Aug.

2021
AOU San Luigi di Orbassano

Mansfield AS; Herbst RS; de Castro G Jr; Hui R; Peled N; Kim DW; Novello S; Satouchi M; Wu YL; Garon EB; Reck M; Robinson AG; Samkari A; Piperdi B; Ebiana V; Lin J; Mok TSK;

Liquid Biopsy for Advanced Non-Small Cell Lung Cancer (NSCLC): A Statement Paper from the IASLC. in Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer / J Thorac Oncol. 2018 Sep;13(9):1248-1268. doi: 10.1016/j.jtho.2018.05.030. Epub 2018 Jun 6.

2018
AOU San Luigi di Orbassano

Rolfo C; Mack PC; Scagliotti GV; Baas P; Barlesi F; Bivona TG; Herbst RS; Mok TS; Peled N; Pirker R; Raez LE; Reck M; Riess JW; Sequist LV; Shepherd FA; Sholl LM; Tan DSW; Wakelee HA; Wistuba II; Wynes MW; Carbone DP; Hirsch FR; Gandara DR;

Update on International Cooperative Groups Studies in Thoracic Malignancies: The Emergence of Immunotherapy. in Clinical lung cancer / Clin Lung Cancer. 2018 Sep;19(5):377-386. doi: 10.1016/j.cllc.2018.03.004. Epub 2018 Mar 17.

2018
AOU San Luigi di Orbassano

Shukla ND; Salahudeen AA; Taylor GA; Ramalingam SS; Vokes EE; Goss GD; Decker RH; Kelly K; Scagliotti GV; Mok TS; Wakelee HA;

Metastatic non-small cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. in Annals of oncology : official journal of the European Society for Medical Oncology / Ann Oncol. 2018 Oct 1;29(Suppl 4):iv192-iv237. doi: 10.1093/annonc/mdy275.

2018
AOU San Luigi di Orbassano

Planchard D; Popat S; Kerr K; Novello S; Smit EF; Faivre-Finn C; Mok TS; Reck M; Van Schil PE; Hellmann MD; Peters S;

Scientific Advances in Lung Cancer 2015. in Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer / J Thorac Oncol. 2016 May;11(5):613-638. doi: 10.1016/j.jtho.2016.03.012. Epub 2016 Mar 22.

2016
AOU San Luigi di Orbassano

Tsao AS; Scagliotti GV; Bunn PA Jr; Carbone DP; Warren GW; Bai C; de Koning HJ; Yousaf-Khan AU; McWilliams A; Tsao MS; Adusumilli PS; Rami-Porta R; Asamura H; Van Schil PE; Darling GE; Ramalingam SS; Gomez DR; Rosenzweig KE; Zimmermann S; Peters S; Ignatius Ou SH; Reungwetwattana T; Jänne PA; Mok TS; Wakelee HA; Pirker R; Mazières J; Brahmer JR; Zhou Y; et alii...

Second ESMO consensus conference on lung cancer: pathology and molecular biomarkers for non-small-cell lung cancer. in Annals of oncology : official journal of the European Society for Medical Oncology / Ann Oncol. 2014 Sep;25(9):1681-1690. doi: 10.1093/annonc/mdu145. Epub 2014 Apr 8.

2014
AOU San Luigi di Orbassano

Kerr KM; Bubendorf L; Edelman MJ; Marchetti A; Mok T; Novello S; O'Byrne K; Stahel R; Peters S; Felip E;